Predictors of clinical outcome in triple negative breast cancer: An institutional review
Mariano Dioca, E. Mickiewicz(University of Chicago), Lydia Puricelli(Universidad de Buenos Aires), C Monica, Márcia de Figueiredo Pereira, Ana Cecilia Adur, Liliana Gozar, A. Álvarez
Cited by 0
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial
|Journal of Clinical Oncology|2000|318
LEVAMISOLE IN ADVANCED HUMAN BREAST CANCER
|The Lancet|1976|159